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1) Corporate Self-Regulation (SR) in the pharmaceutical sector
2) SR vulnerabilities in corruption prevention
3) Enhancing the effectiveness of SF: Enforced SR and the 
Italian Legislative Decree No 231/2001
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 Compliance system:
“An organisational structure implemented within the company 
and designed to monitor employees’ compliance with 
external and internal standards and rules” (Carson, Mrazek, 
Hawkins, 2008)
• Centralised bodies operating worldwide within the group
• Single authorities present in every business unit (divisional 
Compliance Offices, Legal Departments, etc.) 
1. Corporate self-regulation
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 Duties of the Compliance Officer:
• Establish standards and procedures to prevent and detect corrupt 
conducts
• Conduct risk assessment evaluations
• Deliver practical and periodic communication (also through training 
programmes)
• Provide guidance (also by implementing and publicising the 
anonymous/confidential system to file complaints)
• Monitor (investigations and inspections) 
• Audit and conduct periodic evaluation of CS
• Enforce CS through disciplinary proceedings
Corporate self-regulation
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 Legal framework on liability of legal persons:
1) EU: 
• 1998 Joint Action on Corruption in the Private Sector
• 2002 PIF and its Second Protocol  
• 2005 Convention Against Corruption Involving Public Officials
• 2003 EU Council FD on combating corruption in the private sector
2) CoE: 
• 2002 Criminal Law Convention Against Corruption 
• 2003 Civil Law Convention Against Corruption  
3) OECD:
• Convention on Combating Bribery of Foreign Public Officials in International Business 
Transactions 1999
• 2009  Recommendation of the Council for Further Combating Bribery 
• 2009 Recommendation on the Tax Deductibility of Bribes to Foreign Public Officials
• 1976 Guidelines for MNEs
4) UNCAC 2005
Corporate self-regulation
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 The Pharma sector is particularly exposed to the risk of corruption 
(TI, 2009):
• Level of governmental involvement in a number of core decision-points 
(Cohen, Mrazek, Hawkins, 2008):
• Market authorisation and registration
• Drug selection (reimbursement lists) and price setting
• Procurement
• Distribution 
• Prescribing and dispensing
• Inspection
 Forms of corruption occurring in the sector (Vander Beken, 2007):
• Gifts and lavish consulting fees rewarding ‘good’ prescribing behaviour
• Financial support to medical journal and journalists
• Financial support to university pharma research
The Pharmaceutical Sector
Preventing private sector corruption through corporate self-regulation 
May 12, 2013
6
research publications conferences consultancy
www.ircp.org
Anna Di Ronco
+32 9 264 69 71
Anna.DiRonco@UGent.be   
 Pharma industry invests heavily in the promotion of its medicines. 
In 2010 promotional expenditure increased (PM Group):
-0.5 % in the top five developed markets (France, Germany, Italy, Spain and the UK)
-2.2 % in the rest of Europe
 Drug promotion: 
• Sale reps (‘performance bonus’)
• Third parties (subsidiaries, distributors, wholesalers, consultants, vendors, 
etc.) 
 U.S. SEC 2012 FCPA enforcement actions:
•Payments improperly recorded as legitimate expenses for promotional activities
•‘Black money’ created through false or padded invoices (also through collusive vendors, e.g., 
travel agencies, restaurants, etc.)
•(Pfizer and the so-called ‘Point Programme’)
A risky area: product sale and marketing
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 Research project: 
• MNEs identification: 
-11 Pharma MNEs in the TI 2012 Report on Transparency in Corporate Reporting 
- Targeted: 3 Belgian branches of top-scoring pharma MNEs
• Research activities: 
- Interviews with 3 Compliance Officers
• Provisional findings: 
- The compliance system has been poorly developed. Fault lines:
• Risk assessment
• Standards’ dissemination and training
• Guidance and whistle-blowing systems
• Monitoring of sale reps
 Reports confirming the findings (PricewaterhouseCoopers 2008)
2. Vulnerabil it ies of Self-Regulation
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 The Theory of Enforced Self-Regulation (Ayres and Braithwaite, 
1992)
Companies are better suited than external governmental 
agencies to prevent crime:
• Rules are tailored to match the company’s set of risks associated with its way of 
doing business
• Rules adjust more quickly to changing legal and business environments (potential 
to engender creative solutions)
• Rules are more likely to be embedded in the corporate culture and ethos and 
abided by employees
• Internal control systems are more likely to be effective in monitoring and detecting 
employees’ compliance with rules
3. Enhancing Self-Regulation
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Hindrance: companies might not necessarily be willing to spend time 
and resources to make CS effective, unless tangible benefits are 
offered (“positive incentives” in Ruhnka and Boerstler 1998)
2-step model:
1. Public enforcement of privately written rules (approval of the corporate 
self-regulatory scheme)
2. Public monitored private enforcement of those rules (application of a 
lenient sanctioning regime in the trail phase)
Examples in: 
- US, UK, Austria, Spain and Italy (Legislative Decree No 231/2001)
Enforced self-regulation
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 The Italian Legislative Decree 231/2001:
Model of criminal liability that applies to companies when the offence 
has been committed in its interest by:
- An individual in prominent position within the firm (art. 5, let. a)
‘Persons who represent, manage or direct the entity or sub-unit with financial and functional 
autonomy; or persons who exercise, also de facto, the management or control thereof’
- A subordinate (let. b)
When deriving from organisational failure (art. 6 and 7), i.e. the 
absence or ineffectiveness of their organisational models  (CS)
Enforced self-regulation
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 The Italian Legislative Decree 231/2001:
 Discharged criminal liability 
 Mitigated sentence
If the company proves:
• The adoption of an organisational model containing:
• Risk assessment
• Protocols on standards and procedures to prevent crimes
• Regular updates and appropriate financial resources
• Disciplinary system and sanctions
• The existence of an internal supervisory body with autonomous and independent 
powers 
• The circumstance that the offence, when committed by high-level management, is 
an expression of an abnormal behaviour (not of structural negligence)
Enforced self-regulation
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 (Legislative) minimum requirements for effective CS: 
• Standards and procedures to prevent and detect corrupt conducts
• Risk assessment evaluations
• Practical and periodic communication
• Guidance
• Monitoring mechanisms (investigations and inspections) 
• Audits and periodic evaluations of CS
• Enforcement of CS through disciplinary proceedings
 Tangible benefits for companies in the trial phase (mitigation of the 
sentence, exclusion of liability, deferred prosecution agreements, amnesty 
programmes, etc.) – SR integrated in the criminal justice system
Enforced self-regulation
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